Abstract
Genes are the blueprints for proteins and serve as building blocks for tissues. Genes are regulators of chemical reactions inside the living cells. Mutation in a gene causes a change in the expressed structure of protein leading to protein dysfunction. Genetic errors disrupt gene expression and result in diseases. Advancement in biotechnology has helped in understanding the genetic basis of inherited diseases. Gene therapy is an experimental technique that uses genes as medicine for correcting defective genes that are responsible for disease development. Gene therapy has the potential to eliminate a wide range of inherited and acquired human diseases. A number of clinical trials in gene therapy are being carried out throughout the world. Gene therapy approach involves the treatment of disease by introducing new genetic instructions into the tissues of patients to correct the defective or abnormal gene. In gene therapy, mostly somatic (nonsex) cells are targeted for treatment. Due to controversies associated with the involvement of germ cells, this therapy is not attempted. As somatic gene therapy is directed at the individual, it has no impact on future generations. Changes directed at somatic cells are not inherited. The problem of “gene delivery” i.e., the need to get replacement genes into the desired tissues is the most difficult part and needs intensive research. The majority of current gene therapy clinical trials involve the mechanisms of viruses as “vectors”. These viral vectors are capable of integrating at random sites in the host’s cells. To date, gene therapy is being used to treat several genetic disorders. A large number of clinical trials are underway to test gene therapy as a treatment of choice for many life-threatening diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aartsma-Rus A, van Ommen GJ (2007) Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. RNA 13:1609–1624
Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360(5):447–458
Buchschacher GL (2001) Introduction to retroviruses and retroviral vectors. Somat Cell Mol Genet 26:1–11
Bushman FD (2007) Retroviral integration and human gene therapy. J Clin Invest 117(8):2083–2086
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466):669–672
Conese M, Ascenzioni F, Boyd AC (2011) Gene and cell therapy for cystic fibrosis: from bench to bedside. J Cystic Fibr 10(2):S114–S128
Deanna C, Burmester JK (2006) Gene therapy for cancer treatment: past, present and future. Clin Med Res 4(3):218–227
Li SD, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313–1319
Mandel RJ, Manfredsson FP, Foust KD, Rising A, Reimsnider S, Nash K, Burger C (2006) Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther 13:463–483
Miller DG, Rutledge EA, Russell DW (2002) Chromosomal effects of adeno-associated virus vector integration. Nat Genet 30:147–148
Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647–1652
Pelletier R, Caron SO, Puymirat J (2006) RNA based gene therapy for dominantly inherited diseases. Curr Gene Ther 6:131–146
Patterson S, Papagatsias T, Benlahrech A (2009) Use of adenovirus in vaccines for HIV. Handb Exp Pharmacol 275–293
St George JA (2003) Gene therapy progress and prospects: adenoviral vectors. Gene Ther 10:1135–1141
Suzuki S, Tadakuma T, Kunitomi M, Takayama E, Sato M, Asano T (2001) Liposome-mediated gene therapy using HSV-TK/Ganciclovir under the control of human PSA promoter in prostate cancer cells. Urol Int 67:216–223
Weidhaas JB, Angelichio EL, Fenner S, Coffin JM (2000) Relationship between retroviral DNA integration and gene expression. J Virol 74(18):8382–8389
Wolff JA, Budker V (2005) The mechanism of naked DNA uptake and expression. Adv Genet 54:3–20
Woods NB, Bottero V (2006) Gene therapy: therapeutic gene causing lymphoma. Nature 440(7088):1123
Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol Ther 14:316–327
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Rohini, K. (2014). Gene Therapy. In: Ravi, I., Baunthiyal, M., Saxena, J. (eds) Advances in Biotechnology. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1554-7_4
Download citation
DOI: https://doi.org/10.1007/978-81-322-1554-7_4
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1553-0
Online ISBN: 978-81-322-1554-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)